# Ziprasidone in Pediatric Bipolar Disorder

> **NCT00622739** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 28 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Ziprasidone
- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT00622739
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622739, "Ziprasidone in Pediatric Bipolar Disorder". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00622739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*